Antioxidant status in the liver of hypertensive and metallothionein- deficient mice

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 10, 2003, Pages 929-936

  Bobillier Chaumont, Sylvie ^a   Nicod, Laurence ^a   Richert, Lysiane ^a   Berthelot, Alain ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

DOCA salt hypertension; Hepatic antioxidant enzymes; Metallothionein; Transgenic mice

Indexed keywords

ANTIOXIDANT; CATALASE; DEOXYCORTICOSTERONE ACETATE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IRON; LIVER ENZYME; METALLOTHIONEIN; MINERAL; MINERALOCORTICOID; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART; HYPERTENSION; LIVER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SALT INTAKE; TRANSGENIC MOUSE;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BODY WEIGHT; CATALASE; DESOXYCORTICOSTERONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEART RATE; HYPERTENSION; LIVER; MALE; METALLOTHIONEIN; MICE; MICE, TRANSGENIC; MYOCARDIUM; SUPEROXIDE DISMUTASE;

EID: 0347384220     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-089     Document Type: Article

References (56)

1. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105: 121-126.
2. Bellomo, G., Mirabelli, F., DiMonte, D., Richelmi, P., Thor, H., Orrenius, C., and Orrenius, S. 1987. Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-naphthoquinone). Biochem. Pharmacol. 36: 1313-1320.
3. Beswick, R.A., Zhang, H., Marable, D., Catravas, J.D., Hill, W.D., and Webb, R.C. 2001. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension, 37: 781-786.
4. Binda, D., Nicod, L., Viollon-Abadie, C., Rodriguez, S., Berthelot, A., Coassolo, P., and Richert, L. 2001. Strain difference (WKY, SPRD) in the hepatic antioxidant status in rat and effect of hypertension (SHR, DOCA). Ex vivo and in vitro data. Mol. Cell. Biochem. 218: 139-146.
5. Bui, L.M., Keen, C.L., and Dubick, M.A. 1995. Comparative effects of 6-week nicotine treatment on blood pressure and components of the antioxidant system in male spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY) rats. Toxicology, 98: 57-63.
6. Cabell, K.S., Ma, L., and Johnson, P. 1997. Effects of antihypertensive drugs on rat tissue antioxidant enzyme activities and lipid peroxidation levels. Biochem. Pharmacol. 54: 133-141.
7. Carlberg, I., and Mannervik, B. 1985. Glutathione reductase. Methods Enzymol. 113: 484-490.
8. Conrad, C.C., Grabowski, D.T., Walter, C.A., Sabia, M., and Richardson, A. 2000. Using MT(-/-) mice to study metallothionein and oxidative stress. Free Radic. Biol. Med. 28: 447-462.
9. Dhalla, N.S., Elmoselhi, A.B., Hata, T., and Makino, N. 2000. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc. Res. 47: 446-456.
10. Ding, H.Q., Zhou, B.J., Liu, L., and Cheng, S. 2002. Oxidative stress and metallothionein expression in the liver of rats with severe thermal injury. Burns, 28: 215-221.
11. Domanski, L., Pietrzak-Nowacka, M., Szmatloch, E., Wojcicki, J., and Drozdzik, M. 2001. [Malonyldialdehyde, uric acid and white cell count as markers of oxidative stress in acute myocardial infarction and acute coronary insufficiency]. Pol. Merkuriusz Lek. 11: 121-124. [In Polish.]
12. Duarte, J., Galisteo, M., Ocete, M.A., Perez-Vizcaino, F., Zarzuelo, A., and Tamargo, J. 2001. Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats. Mol. Cell. Biochem. 221: 155-160.
13. Eaton, D.L., and Cherian, M.G. 1991. Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. Methods Enzymol. 205: 83-88.
14. Ebadi, M., Hiramatsu, M., and Shiraga, H. 1996. Zinc metallothionein isoforms in free radical-mediated striatal damage in Parkinson's disease. Free Radic. Brain Physiol. Dis. 11: 141-156.
15. Elhaimeur, F., Courderot-Masuyer, C., Nicod, L., Guyon, C., Richert, L., and Berthelot, A. 2002. Dietary vitamin C supplementation decreases blood pressure in DOCA-salt hypertensive male Sprague-Dawley rats and this is associated with increased liver oxidative stress. Mol. Cell. Biochem. 237: 77-83.
16. Emanueli, C., Fink, E., Milia, A.F., Salis, M.B., Conti, M., Demontis, M.P., and Madeddu, P. 1998. Enhanced blood pressure sensitivity to deoxycorticosterone in mice with disruption of bradykinin B2 receptor gene. Hypertension, 31: 1278-1283.
17. Farrell, G.C. 1994. Biochemical mechanisms. In Drug-induced liver disease. Edited by S. Khullar. Churchill Livingstone, London, pp. 23-60.
18. Flohe, L., and Otting, F. 1984b. Superoxide dismutase assays. Methods Enzymol. 105: 93-104.
19. Galley, H.F., Thornton, J., Howdle, P.D., Walker, B.E., and Webster, N.R. 1997. Combination oral antioxidant supplementation reduces blood pressure. Clin. Sci. (London), 92: 361-365.
20. Haramaki, N., Stewart, D.B., Aggarwal, S., Ikeda, H., Reznick, A.Z., and Packer, L. 1998. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion. Free Radic. Biol. Med. 25: 329-339.
21. Hidalgo, J., Campmany, L., Borras, M., Garvey, J.S., and Armario, A. 1988. Metallothionein response to stress in rats: role in free radical scavenging. Am. J. Physiol. 255: E518-E524.
22. Himeno, S. 2002. Application of metallothionein null cells to investigation of cadmium transport. J. Inorg. Biochem. 88: 207-212.
23. Hong, H., and Johnson, P. 1995. Antioxidant enzyme activities and lipid peroxidation levels in exercised and hypertensive rat tissues. Int. J. Biochem. Cell Biol. 27: 923-931.
24. Horikawa, S., Yoneya, R., Nagashima, Y., Hagiwara, K., and Ozasa, H. 2002. Prior induction of heme oxygenase-1 with glutathione depletor ameliorates the renal ischemia and reperfusion injury in the rat. FEBS Lett. 510: 221-224.
25. Ito, H., Torii, M., and Suzuki, T. 1992. A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium. Comp. Biochem. Physiol. B, 103: 37-40.
26. Johns, C., Gavras, I., Handy, D.E., Salomao, A., and Gavras, H. 1996. Models of experimental hypertension in mice. Hypertension, 28: 1064-1069.
27. Kagi, J.H., and Kojima, Y. 1987. Chemistry and biochemistry of metallothionein. Experientia Suppl. 52: 25-61.
28. Laursen, J.B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B.A., and Harrison, D.G. 1997. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation, 95: 588-593.
29. Lawrence, R.A., and Burk, R.F. 1976. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 71: 952-958.
30. Lazo, J.S., Kondo, Y., Dellapiazza, D., Michalska, A.E., Choo, K.H., and Pitt, B.R. 1995. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J. Biol. Chem. 270: 5506-5510.
31. Liu, Y., Liu, J., and Klaassen, C.D. 2001. Metallothionein-null and wild-type mice show similar cadmium absorption and tissue distribution following oral cadmium administration. Toxicol. Appl. Pharmacol. 175: 253-259.
32. Lopez Farre, A., and Casado, S. 2001. Heart failure, redox alterations, and endothelial dysfunction. Hypertension, 38: 1400-1405.
33. Markant, A., and Pallauf, J. 1996. Metallothionein and zinc as potential antioxidants in radical-induced lipid peroxidation in cultured hepatocytes. J. Trace Elem. Med. Biol. 10: 88-95.
34. Masters, B.A., Kelly, E.J., Quaife, C.J., Brinster, R.L., and Palmiter, R.D. 1994. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. U.S.A. 91: 584-588.
35. McCord, J.M., and Fridovich, I. 1969b. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244: 6049-6055.
36. Michalska, A.E., and Choo, K.H. 1993. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. U.S.A. 90: 8088-8092.
37. Min, K.S., Nishida, K., and Onosaka, S. 1999. Protective effect of metallothionein to ras DNA damage induced by hydrogen peroxide and ferric ion-nitrilotriacetic acid. Chem. Biol. Interact. 122: 137-152.
38. Nakagawa, I., Nishi, E., Naganuma, A., and Imura, N. 1995. Effect of preinduction of metallothionein synthesis on clastogenicity of anticancer drugs in mice. Mutat. Res. 348: 37-43.
39. 1-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation, 105: 393-396.
40. Nicod, L., Rodriguez, S., Letang, J.M., Viollon-Abadie, C., Jacqueson, A., Berthelot, A., and Richert, L. 2000a. Antioxidant status, lipid peroxidation, mixed function oxidase and UDP-glucuronyl transferase activities in livers from control and DOCA-salt hypertensive male Sprague Dawley rats. Mol. Cell. Biochem. 203: 33-39.
41. Nicod, L., Rodriguez, S., Jacqueson, A., Viollon-Abadie, C., Berthelot, A., and Richert, L. 2000b. Clofibric acid or diethylmaleate supplemented diet decrease blood pressure in DOCA-salt treated male Sprague Dawley rats - relation with liver anti-oxidant status. Mol. Cell. Biochem. 213: 65-73.
42. Parik, T., Allikmets, K., Teesalu, R., and Zilmer, M. 1996. Evidence for oxidative stress in essential hypertension: perspective for antioxidant therapy. J. Cardiovasc. Risk, 3: 49-54.
43. Park, J.D., Liu, Y., and Klaassen, C.D. 2001. Protective effect of metallothionein against the toxicity of cadmium and other metals. Toxicology, 163: 93-100.
44. Raij, L., Dalmasso, A.P., Staley, N.A., and Fish, A.J. 1989. Renal injury in DOCA-salt hypertensive C5-sufficient and C5-deficient mice. Kidney Int. 36: 582-592.
45. Romero-Alvira, D., and Roche, E. 1996. High blood pressure, oxygen radicals and antioxidants: etiological relationships. Med. Hypotheses, 46: 414-420.
46. Ross, J.S., Stagliano, N.E., Donovan, M.J., Breitbart, R.E., and Ginsburg, G.S. 2001. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann. N.Y. Acad. Sci. 947: 271-292; discussion 292-293.
47. Satoh, M., Aoki, Y., and Tohyama, C. 1997. Protective role of metallothionein in renal toxicity of cisplatinum. Cancer Chemother. Pharmacol. 40: 358-362.
48. 2α. Hypertension, 33: 424-428.
49. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., and Klenk, D.C. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
50. Vallee, B.L. 1991. Introduction to metallothionein. Methods Enzymol. 205: 3-7.
51. Vericel, E., Narce, M., Ulmann, L., Poisson, J.P., and Lagarde, M. 1994. Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol. Cell. Biochem. 132: 25-29.
52. Wang, G.W., and Kang, Y.J. 1999. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels. J. Pharmacol. Exp. Ther. 288: 938-944.
53. 2 toxicity. Am. J. Physiol. 276: H167-H175.
54. Wu, R., Lamontagne, D., and de Champlain, J. 2002. Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation, 105: 387-392.
55. Yuan, Y.V., Kitts, D.D., and Godin, D.V. 1998. Variations in dietary fat and cholesterol intakes modify antioxidant status of SHR and WKY rats. J. Nutr. 128: 1620-1630.
56. Zalba, G., San Jose, G., Moreno, M.U., Fortuno, M.A., Fortuno, A., Beaumont, F.J., and Diez, J. 2001. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension, 38: 1395-1399.